<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Exicure, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Exicure, Inc.

    Exicure, Inc. is a clinical stage biotechnology company developing a new class of immunomodulatory and gene regulating drugs against validated targets. Exicure's proprietary 3-dimensional, spherical nucleic acid (SNA™) architecture unlocks the potential of therapeutic oligonucleotides in a wide range of cells and tissues. Exicure's lead programs address oncology, inflammatory diseases and genetic disorders. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      David A. Giljohann
    • FOUNDED
      2009
    • EMPLOYEES
      20
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Neuralstem, Inc.

    Neuralstem, Inc.

    Neuralstem is a biopharmaceutical company developing novel treatments for nervous ...

    Neuralstem is a biopharmaceutical company devel...

    Filing Type:    PU
    Corbus Pharmaceuticals Holdings, Inc.

    Corbus Pharmaceuticals Holdings, Inc.

    Corbus Pharmaceuticals Holdings, Inc. is a Phase 3 clinical-stage pharmaceutical c...

    Corbus Pharmaceuticals Holdings, Inc. is a Phas...

    Filing Type:    PU
    Alnylam Pharmaceuticals, Inc.

    Alnylam Pharmaceuticals, Inc.

    Alnylam is leading the translation of RNA interference (RNAi) into a whole new cla...

    Alnylam is leading the translation of RNA inter...

    Filing Type:    PU
    Anavex Life Sciences Corp.

    Anavex Life Sciences Corp.

    Anavex utilizes precision genetic medicine to treat severe and devastating neurolo...

    Anavex utilizes precision genetic medicine to t...

    Filing Type:    PU
    Dova Pharmaceuticals, Inc.

    Dova Pharmaceuticals, Inc.

    Dova is a pharmaceutical company focused on acquiring, developing and commercializ...

    Dova is a pharmaceutical company focused on acq...

    Filing Type:    PU
    SELLAS Life Sciences Group, Inc.

    SELLAS Life Sciences Group, Inc.

    SELLAS Life Sciences Group, Inc. is a late-stage biopharmaceutical company focused...

    SELLAS Life Sciences Group, Inc. is a late-stag...

    Filing Type:    PU
    Galectin Therapeutics Inc.

    Galectin Therapeutics Inc.

    Galectin Therapeutics is a biotechnology company focused on discovery and developm...

    Galectin Therapeutics is a biotechnology compan...

    Filing Type:    PU
    Enochian Biosciences, Inc.

    Enochian Biosciences, Inc.

    Enochian Biosciences is a pre-clinical stage biotechnology company committed to us...

    Enochian Biosciences is a pre-clinical stage bi...

    Filing Type:    PU
    Salarius Pharmaceuticals, Inc.

    Salarius Pharmaceuticals, Inc.

    Salarius Pharmaceuticals, Inc. is a clinical-stage oncology company targeting the ...

    Salarius Pharmaceuticals, Inc. is a clinical-st...

    Filing Type:    PU
    Theravance Biopharma, Inc.

    Theravance Biopharma, Inc.

    Theravance Biopharma is a diversified biopharmaceutical company with the core purp...

    Theravance Biopharma is a diversified biopharma...

    Filing Type:    PU
    Forward Pharma A/S

    Forward Pharma A/S

    Forward Pharma A/S is a Danish biopharmaceutical company that commenced developmen...

    Forward Pharma A/S is a Danish biopharmaceutica...

    Filing Type:    PU
    Akari Therapeutics Plc

    Akari Therapeutics Plc

    Akari is a biopharmaceutical company focused on developing inhibitors of acute and...

    Akari is a biopharmaceutical company focused on...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.